Skip to main content

Fluad FDA Approval History

Last updated by Judith Stewart, BPharm on Oct 28, 2020.

FDA Approved: Yes (First approved November 24, 2015)
Brand name: Fluad
Generic name: influenza vaccine, adjuvanted
Dosage form: Injection
Company: Seqirus
Treatment for: Influenza Prophylaxis

Fluad (influenza vaccine, adjuvanted) is an inactivated influenza virus vaccine indicated for the prevention of seasonal influenza in people 65 years of age and older.

Development timeline for Fluad

Nov 24, 2015Approval FDA Approves Fluad (influenza vaccine, adjuvanted) for Prevention of Seasonal Influenza

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.